Tzu‐Ting Huang

1.7k total citations
58 papers, 1.3k citations indexed

About

Tzu‐Ting Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tzu‐Ting Huang has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Tzu‐Ting Huang's work include PARP inhibition in cancer therapy (11 papers), DNA Repair Mechanisms (9 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Tzu‐Ting Huang is often cited by papers focused on PARP inhibition in cancer therapy (11 papers), DNA Repair Mechanisms (9 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Tzu‐Ting Huang collaborates with scholars based in Taiwan, United States and Czechia. Tzu‐Ting Huang's co-authors include Ling‐Ming Tseng, Jungmin Lee, Chun‐Yu Liu, Erika J. Lampert, Chia‐Han Lee, Hsin‐Chen Lee, Kuo‐Hung Huang, Kai‐Wen Hsu, Kuen‐Feng Chen and Chung-Wai Shiau and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Tzu‐Ting Huang

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tzu‐Ting Huang Taiwan 24 826 424 415 172 124 58 1.3k
Vera Levina United States 13 581 0.7× 296 0.7× 688 1.7× 141 0.8× 178 1.4× 18 1.1k
Diana J. Azzam United States 13 1.1k 1.4× 618 1.5× 549 1.3× 127 0.7× 236 1.9× 23 1.6k
Lakshmi Reddy Bollu United States 15 565 0.7× 319 0.8× 233 0.6× 154 0.9× 154 1.2× 24 930
Allie Fu United States 22 1.3k 1.5× 743 1.8× 462 1.1× 263 1.5× 193 1.6× 30 2.1k
Estefanía Carrasco‐García Spain 25 817 1.0× 412 1.0× 387 0.9× 116 0.7× 89 0.7× 37 1.4k
Guanmin Jiang China 17 675 0.8× 242 0.6× 399 1.0× 100 0.6× 296 2.4× 19 1.2k
Mahmut Yilmaz Switzerland 7 681 0.8× 295 0.7× 435 1.0× 106 0.6× 178 1.4× 7 1.3k
Niantao Deng Australia 18 968 1.2× 676 1.6× 329 0.8× 175 1.0× 140 1.1× 29 1.5k
Aijun Zhang United States 15 755 0.9× 522 1.2× 394 0.9× 185 1.1× 368 3.0× 26 1.6k
Chun‐Peng Liao United States 19 580 0.7× 198 0.5× 330 0.8× 307 1.8× 150 1.2× 31 1.1k

Countries citing papers authored by Tzu‐Ting Huang

Since Specialization
Citations

This map shows the geographic impact of Tzu‐Ting Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzu‐Ting Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzu‐Ting Huang more than expected).

Fields of papers citing papers by Tzu‐Ting Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tzu‐Ting Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzu‐Ting Huang. The network helps show where Tzu‐Ting Huang may publish in the future.

Co-authorship network of co-authors of Tzu‐Ting Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Tzu‐Ting Huang. A scholar is included among the top collaborators of Tzu‐Ting Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tzu‐Ting Huang. Tzu‐Ting Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Tzu‐Ting, et al.. (2024). AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer. Cancer Research. 84(6). 887–904. 13 indexed citations
3.
Huang, Tzu‐Ting, Jayakumar R. Nair, Daniel An, et al.. (2023). BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer. Science Translational Medicine. 15(701). eadd7872–eadd7872. 17 indexed citations
4.
Huang, Tzu‐Ting, et al.. (2022). Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor–resistant cancer. Pharmacological Research. 178. 106162–106162. 73 indexed citations
5.
Cheng, Skye Hung‐Chun, et al.. (2022). Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan. Journal of the Formosan Medical Association. 121(8). 1588–1595. 1 indexed citations
6.
Liu, Chunyu, Tzu‐Ting Huang, Pei‐Yi Chu, et al.. (2021). Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer. Frontiers in Oncology. 11. 620361–620361. 20 indexed citations
7.
Huang, Tzu‐Ting, Jayakumar R. Nair, Xiaohu Zhang, et al.. (2020). Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer. Cancer Research. 80(23). 5380–5392. 23 indexed citations
8.
Huang, Tzu‐Ting, et al.. (2020). Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer. Cancer Treatment Reviews. 86. 102021–102021. 109 indexed citations
9.
Nair, Jayakumar R., Tzu‐Ting Huang, Junko Murai, et al.. (2020). Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer. Oncogene. 39(33). 5520–5535. 30 indexed citations
10.
Chiu, Jen‐Hwey, Ling‐Ming Tseng, Tzu‐Ting Huang, et al.. (2020). MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation. Scientific Reports. 10(1). 8060–8060. 7 indexed citations
11.
Huang, Tzu‐Ting, Ling‐Ming Tseng, Ji‐Lin Chen, et al.. (2020). Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression. EBioMedicine. 54. 102717–102717. 34 indexed citations
12.
Liu, Chun‐Yu, Kuen‐Feng Chen, Pei‐Yi Chu, et al.. (2017). Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells. Journal of Molecular Medicine. 95(9). 965–975. 22 indexed citations
13.
Hsu, Chia‐Chi, Chia‐Han Lee, Tzu‐Ting Huang, et al.. (2017). Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells. PLoS ONE. 12(12). e0189007–e0189007. 49 indexed citations
14.
Cheng, Skye Hung‐Chun, et al.. (2016). An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients. EBioMedicine. 5. 74–81. 19 indexed citations
15.
Liu, Chun‐Yu, Tzu‐Ting Huang, Chun‐Teng Huang, et al.. (2016). EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. European Journal of Cancer. 72. 112–123. 37 indexed citations
16.
Huang, Tzu‐Ting, Tien-Shun Yeh, Kai‐Wen Hsu, et al.. (2016). miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells. PLoS ONE. 11(12). e0168171–e0168171. 35 indexed citations
17.
Kalkanis, Steven N., Doug J. Jolly, Derek Ostertag, et al.. (2014). AT-29 * INTRAVENOUS ADMINISTRATION OF TOCA 511 IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 16(suppl 5). v15–v15. 2 indexed citations
18.
Hsu, Kai‐Wen, Anming Wang, Yueh‐Hsin Ping, et al.. (2013). Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis. Carcinogenesis. 35(1). 208–217. 41 indexed citations
19.
Huang, Tzu‐Ting, David H. Peng, Hsin‐Fu Chen, et al.. (2011). Exacerbation of Oxidative Stress-Induced Cell Death and Differentiation in Induced Pluripotent Stem Cells Lacking Heme Oxygenase-1. Stem Cells and Development. 21(10). 1675–1687. 33 indexed citations
20.
Huang, Tzu‐Ting, Meng‐Chi Yen, Chi‐Chen Lin, et al.. (2011). Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Science. 102(12). 2214–2220. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Levina Breakdown of academic impact, for papers by Diana J. Azzam Breakdown of academic impact, for papers by Lakshmi Reddy Bollu Breakdown of academic impact, for papers by Allie Fu Breakdown of academic impact, for papers by Estefanía Carrasco‐García Breakdown of academic impact, for papers by Guanmin Jiang Breakdown of academic impact, for papers by Mahmut Yilmaz Breakdown of academic impact, for papers by Niantao Deng Breakdown of academic impact, for papers by Aijun Zhang Breakdown of academic impact, for papers by Chun‐Peng Liao
Rankless by CCL
2026